DE602004029477D1 - Methode zur detektion und beobachtung von krankheiten durch analyse von an den zellen gebundenen nukleinsäuren - Google Patents

Methode zur detektion und beobachtung von krankheiten durch analyse von an den zellen gebundenen nukleinsäuren

Info

Publication number
DE602004029477D1
DE602004029477D1 DE602004029477T DE602004029477T DE602004029477D1 DE 602004029477 D1 DE602004029477 D1 DE 602004029477D1 DE 602004029477 T DE602004029477 T DE 602004029477T DE 602004029477 T DE602004029477 T DE 602004029477T DE 602004029477 D1 DE602004029477 D1 DE 602004029477D1
Authority
DE
Germany
Prior art keywords
nucleic acids
detection
cells
diseases
monitoring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004029477T
Other languages
English (en)
Inventor
Georg Sczakiel
Valentin Vlassov
Pavel Laktionov
Elena Rykova
Svetlana Tamkovic
Tat Yana Skvortsova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Schleswiger Tauwerkfabrik Oellerking GmbH and Co KG
Universitatsklinikum Schleswig Holstein UKSH
Original Assignee
Schleswiger Tauwerkfabrik Oellerking GmbH and Co KG
Universitatsklinikum Schleswig Holstein UKSH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schleswiger Tauwerkfabrik Oellerking GmbH and Co KG, Universitatsklinikum Schleswig Holstein UKSH filed Critical Schleswiger Tauwerkfabrik Oellerking GmbH and Co KG
Publication of DE602004029477D1 publication Critical patent/DE602004029477D1/de
Anticipated expiration legal-status Critical
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE602004029477T 2003-08-18 2004-08-17 Methode zur detektion und beobachtung von krankheiten durch analyse von an den zellen gebundenen nukleinsäuren Active DE602004029477D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2003125486/15A RU2249820C1 (ru) 2003-08-18 2003-08-18 Способ ранней диагностики заболеваний, связанных с нарушением функционирования генетического аппарата клетки
PCT/EP2004/009218 WO2005017197A2 (en) 2003-08-18 2004-08-17 Method for early detection and monitoring of diseases by analysis of cell-surface-bound nucleic acids

Publications (1)

Publication Number Publication Date
DE602004029477D1 true DE602004029477D1 (de) 2010-11-18

Family

ID=34192339

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004029477T Active DE602004029477D1 (de) 2003-08-18 2004-08-17 Methode zur detektion und beobachtung von krankheiten durch analyse von an den zellen gebundenen nukleinsäuren

Country Status (6)

Country Link
US (1) US20070020636A1 (de)
EP (1) EP1658384B1 (de)
AT (1) ATE483823T1 (de)
DE (1) DE602004029477D1 (de)
RU (1) RU2249820C1 (de)
WO (1) WO2005017197A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2900927C (en) * 2007-07-23 2018-08-14 The Chinese University Of Hong Kong Diagnosing fetal chromosomal aneuploidy using genomic sequencing
US20100112590A1 (en) 2007-07-23 2010-05-06 The Chinese University Of Hong Kong Diagnosing Fetal Chromosomal Aneuploidy Using Genomic Sequencing With Enrichment
US9892230B2 (en) 2012-03-08 2018-02-13 The Chinese University Of Hong Kong Size-based analysis of fetal or tumor DNA fraction in plasma
US10364467B2 (en) 2015-01-13 2019-07-30 The Chinese University Of Hong Kong Using size and number aberrations in plasma DNA for detecting cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3721400A1 (de) * 1987-06-29 1989-01-12 Viktor Dr Dr Med Balazs Verfahren zur untersuchung einer azellularen biologischen fluessigkeit auf zellulare onkogen-dna bzw. deren fragmente
US6156504A (en) * 1996-03-15 2000-12-05 The Penn State Research Foundation Detection of extracellular tumor-associated nucleic acid in blood plasma or serum using nucleic acid amplification assays
AU2001279164A1 (en) * 2000-08-01 2002-02-13 Oregon Health And Science University Mammalian dna binding membrane-associated protein-encoding gene and uses

Also Published As

Publication number Publication date
WO2005017197A3 (en) 2005-04-21
EP1658384B1 (de) 2010-10-06
ATE483823T1 (de) 2010-10-15
US20070020636A1 (en) 2007-01-25
EP1658384A2 (de) 2006-05-24
RU2249820C1 (ru) 2005-04-10
RU2003125486A (ru) 2005-02-10
WO2005017197A2 (en) 2005-02-24

Similar Documents

Publication Publication Date Title
AU2002327308A1 (en) Methods for evaluating pathologic conditions using extracellular rna
ATE461294T1 (de) Brustkrebsdiagnoseverfahren
JP2010279394A (ja) 疾患検出のための方法
ATE429495T1 (de) Nukleinsäuren für die apoptose von krebszellen
WO2005040421A3 (en) Prognostic and diagnostic markers for cell proliferative disorders of the breast tissues
ATE545708T1 (de) Krebsantigen mage-a9 und verwendungen davon
WO2004078035A3 (en) Expression profiles for breast cancer and methods of use
WO2007071829A3 (en) Methods and means related to diseases
DE602004029477D1 (de) Methode zur detektion und beobachtung von krankheiten durch analyse von an den zellen gebundenen nukleinsäuren
CN116018646A (zh) 用于表征无细胞核酸片段的方法
WO2005056839A3 (de) Primer und sonden zum nachweis genitaler hpv-genotypen
CA2393864A1 (en) Apparatus and methods for drug screening
Malvandi et al. Gene expression quantification of toll like receptors 2, 4 and co-molecules in human glioblastoma cell line (U87-MG): toward a new in vitro model of inflammation
RU2683251C1 (ru) Способ диагностики светлоклеточного почечно-клеточного рака и способ прогнозирования метастазирования на основе группы генов микроРНК
WO2003093501A3 (en) Ssh based methods for identifying and isolating unique nucleic acid sequences
RU2311640C1 (ru) Способ выделения внеклеточных нуклеиновых кислот из мочи
RU2490638C1 (ru) Способ прогнозирования развития в-клеточных и т-клеточных неходжкинских лимфом
WO2005014804A3 (en) Ubiquitin-specific protease
RU2723090C1 (ru) Способ диагностики предрасположенности к почечно-клеточному раку на основе ПЦР-ПДРФ
RU2721709C1 (ru) Способ прогнозирования риска возникновения почечно-клеточного рака
WO2003040369A3 (fr) Sequences impliquees dans les phenomenes de suppression tumorale, reversion tumorale, apoptose et/ou resistance aux virus et leur utilisation comme medicaments
RU2490642C1 (ru) Способ прогнозирования клинической формы хронического лимфолейкоза
EP4373961A1 (de) Verwendung von genetischen und epigenetischen markern zum nachweis des zelltodes
Gebauer et al. Pyrosequencing as a fast and reliable method in detecting the MYD88 p. L265P mutation in decalcified formalin-fixed and paraffin-embedded tissues
RU2599502C1 (ru) Способ прогнозирования риска развития рака яичников